Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
Other expense was $34 million in the fourth quarter of 2023 on a reported basis, compared to $21 million in the fourth quarter of 2022.
- Other expense was $34 million in the fourth quarter of 2023 on a reported basis, compared to $21 million in the fourth quarter of 2022.
- The reported effective tax rate was negative 11.1% in the fourth quarter of 2023 compared to 39.2% in the fourth quarter of 2022.
- Adjusted EBITDA was $165 million in the fourth quarter of 2023, a decrease of 4% compared to the fourth quarter of 2022.
- Cash provided by operations was $157 million in the fourth quarter of 2023 compared to $13 million in the fourth quarter of 2022.